Abstract Library

#4633 Mini invasive pancreatectomy for pancreatic neuroendocrine tumours: Current state of management in France

Introduction: Pancreatic neuroendocrine tumours (NETs) accounts for 2% of pancreatic tumours and their management is challenging. Surgery is the most radical treatment, but for small lesions, parenchyma sparing techniques are also used.

Conference:

Presenting Author: Muzzolini M

Authors: Muzzolini M, de Ponthaud C, Gaujoux S,

Keywords: laparoscopic NETs surgical outcomes,

#4620 Impact of the extent of surgical resection on the development of post-operative diabetes in patients undergoing distal pancreatectomy for non-functioning pancreatic neuroendocrine tumours (NF-PanNET)

Introduction: Pancreatic neuroendocrine tumours (PanNETs) are often indolent neoplasms. Surgery is the primary curative approach for localised non-functioning (NF) PanNETs, but it poses a risk of long-term complications, such as diabetes, impacting quality of life.

Conference:

Presenting Author:

Authors: Battistella A, Partelli S, Guccinelli E, Prato F, Andreasi V,

Keywords: Pan NET, distal pancreatectomy, post-operative diabetes, surgical extension,

#4463 Evaluating multi-visceral resection for locally advanced and metastatic pancreatic neuroendocrine tumours (PNETs): Feasibility, safety and complications

Introduction: Pancreatic neuroendocrine tumours (PNETs) are rare but clinically significant neoplasms. Surgery can play a significant role in the multimodal treatment of PNETs. Multi-visceral resection involving organs in the left upper quadrant (LUQ) can be used with curative or cytoreductive intent in selected cases.

Conference:

Presenting Author:

Authors: Ee J, Patel R, Hamady Z, Pike T, Karavias D,

Keywords: neuroendocrine, tumour, pancreatic, multivisceral,

#4249 Factors associated with post-operative pancreatic insufficiency after distal pancreatectomy for localised non-functioning pancreatic neuroendocrine tumors (NF-PanNET)

Introduction: Pancreatic Neuroendocrine Tumors (pNETs) are rare neoplasms, often indolent in nature. Surgery is the backbone of curative treatment for localised panNETs. As the majority of these patients are cured by surgery, the development of long-term complications such as post-operative pancreatic insufficiency is critical.

Conference:

Presenting Author: Battistella A

Authors: Battistella A, Partelli S, Andreasi V, Muffatti F, Tamburrino D,

Keywords: PanNET, post-operative pancreatic insufficiency, distal pancreatectomy,

#4180 Non-functional alpha-cell hyperplasia with glucagonoma: A case report

Introduction: Alpha-cell hyperplasia(ACH) is a rare pancreatic endocrine condition. Clinically, 3 types have been described: functional ACH (nonglucagonoma hyperglucagonemic glucagonoma syndrome), reactive ACH (secondary to defective glucagon signalling) and non-functional ACH. Few cases of ACH and non-functional pancreatic neuroendocrine tumors (pNET) have been reported and its aetiology remains poorly understood.

Conference:

Presenting Author: Santos A

Authors: Cidade Rodrigues C, Santos A, Calheiros R, Santos S, Matos C,

Keywords: alpha-cell hyperplasia, diabetes, glucagon, pancreas, neuroendocrine tumor,